Source: Antiviral Therapy. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, BRASILEIROS, PREVALÊNCIA, INFECÇÕES OPORTUNISTAS, HEPATITE C (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA-NETO, Gaspar et al. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Antiviral Therapy, v. 20, p. 281-287, 2015Tradução . . Disponível em: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9. Acesso em: 19 nov. 2024.APA
Lisboa-Neto, G., Noble, C. F., Pinho, J. R. R., Malta, F. M., Gomes-Gouvêa, M. S., Alvarado-Mora, M. V., et al. (2015). Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Antiviral Therapy, 20, 281-287. doi:10.3851/IMP2873NLM
Lisboa-Neto G, Noble CF, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Alvarado-Mora MV, Silva MH da, Leite AGB, Piccoli LZ, Rodrigues FK, Carrilho FJ, Mendes-Correa MC. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection [Internet]. Antiviral Therapy. 2015 ; 20 281-287.[citado 2024 nov. 19 ] Available from: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9Vancouver
Lisboa-Neto G, Noble CF, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Alvarado-Mora MV, Silva MH da, Leite AGB, Piccoli LZ, Rodrigues FK, Carrilho FJ, Mendes-Correa MC. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection [Internet]. Antiviral Therapy. 2015 ; 20 281-287.[citado 2024 nov. 19 ] Available from: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9
